| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/03/2013 | WO2012149186A3 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use |
| 01/03/2013 | WO2012140666A3 Herbal extracts and compositions prepared therefrom |
| 01/03/2013 | WO2012138880A9 Methods of treating inflammatory diseases by targeting the chemoattractant cytokine receptor 2 (ccr2) or chemokine (c-c motif) ligand 2 (ccl2) |
| 01/03/2013 | US20130006351 Polymer coatings containing drug powder of controlled morphology |
| 01/03/2013 | US20130006350 Drug-delivery endovascular stent and method for treating restenosis |
| 01/03/2013 | US20130006182 Pharmaceutical compositions |
| 01/03/2013 | US20130005822 Aerosolized dapsone as a therapy for inflammation of the airway and abnormal mucociliary transport |
| 01/03/2013 | US20130005817 Ketoprofen-Containing Aqueous Adhesive Skin Patch |
| 01/03/2013 | US20130005816 Transdermal compositions of ibuprofen and methods of use thereof |
| 01/03/2013 | US20130005815 Aqueous intraocular penetration-promoting eye drop |
| 01/03/2013 | US20130005813 Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field |
| 01/03/2013 | US20130005805 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | US20130005793 Compositions and Methods for Inhibiting Gene Expression of Hepatitis B Virus |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005762 Combination of droloxifene and clopidogrel |
| 01/03/2013 | US20130005758 Manufacture, method and use of drug-eluting medical devices for permanently keeping blood vessels open |
| 01/03/2013 | US20130005752 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005749 Novel formulation and treatment methods |
| 01/03/2013 | US20130005745 Inhibitors of bruton's tyrosine kinase |
| 01/03/2013 | US20130005743 New positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/03/2013 | US20130005740 Process for preparation of over-the-counter gelatin or pectin-based drug delivery |
| 01/03/2013 | US20130005735 Organic compounds |
| 01/03/2013 | US20130005729 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005726 Compositions and methods for treating inflammatory disorders |
| 01/03/2013 | US20130005721 Indolizine inhibitors of 5-lipoxygenase |
| 01/03/2013 | US20130005718 Compositions and methods of treating chronic pain by administering propofol derivatives |
| 01/03/2013 | US20130005714 Water-Soluble Meloxicam Granules |
| 01/03/2013 | US20130005708 Histamine antagonist treatment of inflammatory skin disorders |
| 01/03/2013 | US20130005707 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith |
| 01/03/2013 | US20130005692 Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome |
| 01/03/2013 | US20130005691 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | US20130005687 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| 01/03/2013 | US20130005686 2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs |
| 01/03/2013 | US20130005681 Compositions and methods for stabilized polysaccharide formulations |
| 01/03/2013 | US20130005676 Enhancing the therapeutic effect of acupuncture with adenosine |
| 01/03/2013 | US20130005659 Il-17 binding compounds and medical uses thereof |
| 01/03/2013 | US20130005645 Apoe peptide dimers and uses thereof |
| 01/03/2013 | US20130005644 Cyclic agonists and antagonists of c5a receptors and g protein-coupled receptors |
| 01/03/2013 | US20130004651 Sustained drug release from body implants using nanoparticle-embedded polymeric coating materials |
| 01/03/2013 | US20130004591 Formulation for relief of cold and flu symptoms |
| 01/03/2013 | US20130004582 Composition and method to alleviate joint pain |
| 01/03/2013 | US20130004576 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect |
| 01/03/2013 | US20130004565 Proteolytic enzyme formulations |
| 01/03/2013 | US20130004540 Bifidobacterium strain |
| 01/03/2013 | US20130004524 Conjugated Proteins |
| 01/03/2013 | US20130004518 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 01/03/2013 | US20130004514 Therapeutic antibodies |
| 01/03/2013 | US20130004512 Nucleic acid molecules encoding bank1 splice variants |
| 01/03/2013 | US20130004508 Engineered anti-tslp antibody |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004495 Anti-ngf antibodies for the treatment of various disorders |
| 01/03/2013 | US20130004491 Antibodies Against Phosphorylcholine In Combination Therapy with Biologic Agents |
| 01/03/2013 | US20130004477 Methods for Treating Inflammation and Oxidative Stress Related Diseases |
| 01/03/2013 | US20130004473 Methods and Biomarkers for the Detection of Dengue Hemorrhagic Fever |
| 01/03/2013 | US20130004467 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 01/03/2013 | US20130004465 Adherent cells from placenta and use of same in disease treatment |
| 01/03/2013 | US20130004428 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 01/03/2013 | US20130004425 Biomineral and Metal Binding Liposomes, Their Synthesis, and Methods of Use Thereof |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | US20130004415 Joint-Homing Peptides and Uses Thereof |
| 01/03/2013 | CA2840577A1 Soluble integrin .alpha.4 mutant |
| 01/03/2013 | CA2840315A1 Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives |
| 01/03/2013 | CA2839622A1 Wap domain fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839398A1 Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders |
| 01/02/2013 | EP2540821A1 Method for producing regulatory dendritic cells |
| 01/02/2013 | EP2539347A2 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 01/02/2013 | EP2539346A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 01/02/2013 | EP2539345A1 4 - [cycloalkyloxy (hetero) arylamino]thieno [2, 3 - d]pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 01/02/2013 | EP2539344A1 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 01/02/2013 | EP2539328A1 Novel water soluble furoxan derivatives having antitumor activity |
| 01/02/2013 | EP2539317A2 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof |
| 01/02/2013 | EP2538964A1 Modulation of cytokine-induced chronic inflammatory responses |
| 01/02/2013 | EP2538959A1 Compounds for the treatment of inflammation and neutropenia |
| 01/02/2013 | EP2538949A1 Silicon-containing biodegradable material for anti-inflammatory therapy |
| 01/02/2013 | EP2538941A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 01/02/2013 | EP2538937A1 Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti - inflammatory agent for the treatment of inflammation and pain in the veterinary field |
| 01/02/2013 | EP2538919A2 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 01/02/2013 | EP2182949B1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 01/02/2013 | CN202637539U Novel rheumatism analgesic ointment |
| 01/02/2013 | CN202637538U Rheumatic pain relieving paste |
| 01/02/2013 | CN202637537U Rheumatism sticking plaster capable of being pasted on wounded skin surface |
| 01/02/2013 | CN202637536U Air permeable plaster for rheumatism |
| 01/02/2013 | CN202637269U Medicinal magnetic acupuncture point plaster |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102858978A High-purity soluble thrombomodulin and method for producing same |
| 01/02/2013 | CN102858782A 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 01/02/2013 | CN102858779A Cyclic tetrapeptides and therapeutic applications thereof |
| 01/02/2013 | CN102858769A Pyrazolopyridine kinase inhibitors |
| 01/02/2013 | CN102858767A Aminopyrimidines as SYK inhibitors |
| 01/02/2013 | CN102858766A Polymorphs of a metabotropic glutamate receptor positive allosteric modulator |
| 01/02/2013 | CN102858764A Pyrimidinyl indole compounds |
| 01/02/2013 | CN102858742A Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 01/02/2013 | CN102858354A Infant and young children feeding formula comprising probiotics for infants and young children |
| 01/02/2013 | CN102858340A Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 01/02/2013 | CN102858339A Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain |
| 01/02/2013 | CN102858332A Ketoprofen-containing aqueous adhesive skin patch |
| 01/02/2013 | CN102858331A Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 01/02/2013 | CN102851112A Preparation method for selenium-rich peony seed essential oil |
| 01/02/2013 | CN102850443A Integrin blocker polypeptides and application thereof |
| 01/02/2013 | CN102850426A A glucocorticoid with 21 site N-acetylcystein ester |